GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: LLP019 is a PROTAC degrader that targets the 3CL (main) protease (Mpro) of SARS-CoV-2 [1]. It is a heterobifunctional molecule that carries a pelitinib-derived warhead to bind an allosteric site of Mpro, linked to 4-hydroxy-thalidomide to engage the cereblon (CRBN) E3 ubiquitin ligase. LLP019 was designed to allow exploration of the anti-viral potential of selective Mpro degradation.
|
|
Bioactivity Comments |
The DC50 for LLP019-mediated degradation of SARS-CoV-2 Mpro is 4.7 μM [1]. |